150 related articles for article (PubMed ID: 38319569)
1. Application of a Specific and Sensitive NQO1 Turn-On Near-Infrared Fluorescence Probe for Live Cancer Cell and Xenografted Tumor Imaging in Nude Mice.
Srivenugopal KS; Arutla V; Punganuru SR; Khan AEMA
Methods Mol Biol; 2024; 2755():63-74. PubMed ID: 38319569
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
[TBL] [Abstract][Full Text] [Related]
3. A near-infrared fluorescent probe with two-photon excitation for in situ imaging of NQO1 in human colorectum cancer tissue.
Jiang W; An W; Huang Z; Xu C; Shen Q; Pu C; Zhang S; Wu Q; Li L; Yu C
Talanta; 2024 Jul; 274():126018. PubMed ID: 38593645
[TBL] [Abstract][Full Text] [Related]
4. High-contrast NIR fluorescent probes for selective detection of NQO1 in breast cancer.
Liu H; Hu F; Cao Z; Qu Y; Wen H; Wang X; Li W
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 311():123898. PubMed ID: 38340443
[TBL] [Abstract][Full Text] [Related]
5. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.
Gong Q; Yang F; Hu J; Li T; Wang P; Li X; Zhang X
Eur J Med Chem; 2021 Nov; 224():113707. PubMed ID: 34303080
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of NQO1 responsive fluorescence probe and its application in bio-imaging for cancer diagnosis.
Yuan Z; Xu M; Wu T; Zhang X; Shen Y; Ernest U; Gui L; Wang F; He Q; Chen H
Talanta; 2019 Jun; 198():323-329. PubMed ID: 30876568
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic NQO1 Enzyme-Activated Near-Infrared Fluorescence Imaging and Photodynamic Therapy with Polymeric Vesicles.
Yao C; Li Y; Wang Z; Song C; Hu X; Liu S
ACS Nano; 2020 Feb; 14(2):1919-1935. PubMed ID: 31935063
[TBL] [Abstract][Full Text] [Related]
9. Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.
Bannas P; Lenz A; Kunick V; Fumey W; Rissiek B; Schmid J; Haag F; Leingärtner A; Trepel M; Adam G; Koch-Nolte F
J Vis Exp; 2015 Apr; (98):e52462. PubMed ID: 25867711
[TBL] [Abstract][Full Text] [Related]
10. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
[TBL] [Abstract][Full Text] [Related]
11. Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo(1).
Phillips RM; Burger AM; Fiebig HH; Double JA
Biochem Pharmacol; 2001 Nov; 62(10):1371-7. PubMed ID: 11709197
[TBL] [Abstract][Full Text] [Related]
12. Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
Cao L; Li LS; Spruell C; Xiao L; Chakrabarti G; Bey EA; Reinicke KE; Srougi MC; Moore Z; Dong Y; Vo P; Kabbani W; Yang CR; Wang X; Fattah F; Morales JC; Motea EA; Bornmann WG; Yordy JS; Boothman DA
Antioxid Redox Signal; 2014 Jul; 21(2):237-50. PubMed ID: 24512128
[TBL] [Abstract][Full Text] [Related]
13. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
Dehn DL; Winski SL; Ross D
Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of a deep tissue penetrating near-infrared two-photon fluorescence probe for the specific detection of NQO1.
Wu W; Li X; Zhao L; Li S; Han J; Zhang Y; Zhao Z
Chem Commun (Camb); 2022 May; 58(37):5634-5637. PubMed ID: 35438109
[TBL] [Abstract][Full Text] [Related]
15. Near-Infrared Fluorogenic Probes with Polarity-Sensitive Emission for in Vivo Imaging of an Ovarian Cancer Biomarker.
Yao D; Lin Z; Wu J
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5847-56. PubMed ID: 26910257
[TBL] [Abstract][Full Text] [Related]
16. Chemiluminescent Probe for the In Vitro and In Vivo Imaging of Cancers Over-Expressing NQO1.
Son S; Won M; Green O; Hananya N; Sharma A; Jeon Y; Kwak JH; Sessler JL; Shabat D; Kim JS
Angew Chem Int Ed Engl; 2019 Feb; 58(6):1739-1743. PubMed ID: 30561862
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer.
Wu X; Li X; Li Z; Yu Y; You Q; Zhang X
J Med Chem; 2018 Dec; 61(24):11280-11297. PubMed ID: 30508483
[TBL] [Abstract][Full Text] [Related]
18. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
[TBL] [Abstract][Full Text] [Related]
19. NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung Cancers.
Motea EA; Huang X; Singh N; Kilgore JA; Williams NS; Xie XJ; Gerber DE; Beg MS; Bey EA; Boothman DA
Clin Cancer Res; 2019 Apr; 25(8):2601-2609. PubMed ID: 30617135
[TBL] [Abstract][Full Text] [Related]
20. An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells.
Cuff S; Lewis RD; Chinje E; Jaffar M; Knox R; Weeks I
Free Radic Biol Med; 2018 Feb; 116():141-148. PubMed ID: 29325897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
